Trial · NCT07901985
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Level of disability (WHODAS 2.0 total score) | Phase1. Baseline survey (at admission) / Phase2. Follow-up survey 1 (approximately 6 months post-discharge) / Phase3. Follow-up survey 2 (approximately 12 months post-discharge) | Level of disability is measured using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). The summary score ranges from 0 to 100, with higher scores indicating greater disability (a worse outcome). |
| Other | Demographic information | Phase1. Baseline survey (at admission) / Phase2. Follow-up survey 1 (approximately 6 months post-discharge) / Phase3. Follow-up survey 2 (approximately 12 months post-discharge) | Name, sex, date of birth, resident registration number, nationality, marital status, education level, region of residence, economic activity (employment) status, occupational category |
| Other | Injury-related information | Phase1. Baseline survey (at admission) | Age at injury, date of injury, mode of transfer after injury, place of residence at the time of injury |
| Other | Neurological status (ISNCSCI) | Phase1. Baseline survey (at admission) | Neurological impairment classified with the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI), reported as the ASIA Impairment Scale (AIS) grade (A = complete to E = normal). |
| Other | Pain intensity (0-10 numeric rating scale) | Phase1. Baseline survey (at admission) / Phase2. Follow-up survey 1 (approximately 6 months post-discharge) / Phase3. Follow-up survey 2 (approximately 12 months post-discharge) | Pain intensity measured with a Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain); higher scores indicate worse pain. |
| Other | Spasticity severity (0-10 numeric rating scale) | Phase1. Baseline survey (at admission) /Phase2. Follow-up survey 1 (approximately 6 months post-discharge) / Phase3. Follow-up survey 2 (approximately 12 months post-discharge) | Spasticity severity rated on a 0-10 numeric scale, where 0 indicates no spasticity and 10 indicates the most severe spasticity; higher scores indicate worse spasticity. |
| Other | Functional ambulation (FAC) | Phase1. Baseline survey (at admission) | Walking ability classified with the Functional Ambulation Category (FAC), ranging from 0 to 5; higher categories indicate more independent walking (better outcome). |
| Other | Hand function (Jebsen-Taylor Hand Function Test) | Phase1. Baseline survey (at admission) | Hand function measured with the Jebsen-Taylor Hand Function Test (JHFT), reported as time to complete the tasks in seconds; shorter time indicates better function. |
| Other | Independence in activities of daily living(SCIM III) | Phase1. Baseline survey (at admission) | Functional independence measured with the Korean version of the Spinal Cord Independence Measure III (K-SCIM-III). Total score ranges from 0 to 100; higher scores indicate greater independence (better outcome). |
| Other | Depression (PHQ-9) | Phase1. Baseline survey (at admission) / Phase2. Follow-up survey 1 (approximately 6 months post-discharge) / Phase3. Follow-up survey 2 (approximately 12 months post-discharge) | Depressive symptoms measured with the Patient Health Questionnaire-9 (PHQ-9). Total score ranges from 0 to 27; higher scores indicate more severe symptoms (worse outcome). |
| Other | Quality of life (EQ-5D) | Phase1. Baseline survey (at admission) / Phase2. Follow-up survey 1 (approximately 6 months post-discharge) / Phase3. Follow-up survey 2 (approximately 12 months post-discharge) | Health-related quality of life measured with the EQ-5D, reported as the EQ-5D index value (range -1 to 1; higher values indicate better health). |
| Other | Post-discharge emergency department visits (number of visits) | Phase2. Follow-up survey 1 (approximately 6 months post-discharge) / Phase3. Follow-up survey 2 (approximately 12 months post-discharge) | Use of emergency department services after discharge, reported as the number of emergency department visits per participant (self-reported in the follow-up surveys). |
| Other | Post-discharge hospital admissions (number of admissions) | Phase2. Follow-up survey 1 (approximately 6 months post-discharge) / Phase3. Follow-up survey 2 (approximately 12 months post-discharge) | Use of inpatient services after discharge, reported as the number of hospital admissions per participant (self-reported in the follow-up surveys). |
| Other | Post-discharge outpatient visits (number of visits) | Phase2. Follow-up survey 1 (approximately 6 months post-discharge) / Phase3. Follow-up survey 2 (approximately 12 months post-discharge) | Use of outpatient services after discharge, reported as the number of outpatient visits per participant (self-reported in the follow-up surveys). |
| Other | Social participation | Phase2. Follow-up survey 1 (approximately 6 months post-discharge) / Phase3. Follow-up survey 2 (approximately 12 months post-discharge) | Participation in social activities (yes/no) and frequency |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07901985/registered